Comment on: "The role of dermocosmetics in the management of cancer-related skin toxicities"
- PMID: 41099779
- DOI: 10.1007/s00520-025-09982-w
Comment on: "The role of dermocosmetics in the management of cancer-related skin toxicities"
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Comment on
-
The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus.Support Care Cancer. 2023 Nov 4;31(12):672. doi: 10.1007/s00520-023-08116-4. Support Care Cancer. 2023. PMID: 37925388 Free PMC article. Review.
References
-
- Dreno B, Khosrotehrani K, De Barros Silva G et al (2023) The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus. Support Care Cancer 31:672. https://doi.org/10.1007/s00520-023-08116-4 - DOI - PubMed - PMC
-
- Giulivo M, Lopez de Alda M, Capri E, Barceló D (2016) Human exposure to endocrine disrupting compounds: their role in reproductive systems, metabolic syndrome, and breast cancer. Environ Res 151:251–264
-
- Darbre PD (2006) Endocrine disruptors and hormone-dependent cancers. Br Med Bull 79–80:11–27
Publication types
LinkOut - more resources
Full Text Sources
